SPRB Spruce Biosciences Appoints Adrian Quartel, M.D., FFPM, as Chief Medical Officer Accomplished Rare Disease Drug Developer Brings More T

SPRB Spruce Biosciences Appoints Adrian Quartel, M.D., FFPM, as Chief Medical Officer Accomplished Rare Disease Drug Developer Brings More Than 25 Years of Global Clinical Development and Medical Affairs Leadership, Including the Launch of Multiple Enzyme Replacement Therapies for Rare Pediatric and Genetic Disorders